Pharma & Healthcare
Global Recombinant Human Transforming Growth Factor-β Market Research Report 2026
- Feb 03, 26
- ID: 693239
- Pages: 142
- Figures: 145
- Views: 4
This report delivers a comprehensive overview of the global Recombinant Human Transforming Growth Factor-β market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Recombinant Human Transforming Growth Factor-β. The Recombinant Human Transforming Growth Factor-β market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Recombinant Human Transforming Growth Factor-β market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human Transforming Growth Factor-β manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher
Abcam
Atlantis Bioscience
Sigma-Aldrich
MedChemExpress
Miltenyi Biotec
Bio-Techne
Proteintech
Cell Guidance Systems
Cell Signaling Technology
Qkine
ACROBiosystems
FUJIFILM Irvine Scientific
Croyez Bioscience
Beijing Sino Biological
Abbkine Scientific
Yeasen Biotechnology (Shanghai)
Dalian Meilun Biotechnology
Shanghai Zhong Qiao Xin Zhou Biotechnology
Suzhou Novoprotein Scientific
Nanjing Okay Biotechnology
Cellverse
Beijing T&L Biotechnology
EIAAB SCIENCE
Shanghai DiLab Biotechnology
Segment by Type
TGF-β1
TGF-β2
TGF-β3
by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human Transforming Growth Factor-β manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Recombinant Human Transforming Growth Factor-β sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Recombinant Human Transforming Growth Factor-β market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Recombinant Human Transforming Growth Factor-β manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher
Abcam
Atlantis Bioscience
Sigma-Aldrich
MedChemExpress
Miltenyi Biotec
Bio-Techne
Proteintech
Cell Guidance Systems
Cell Signaling Technology
Qkine
ACROBiosystems
FUJIFILM Irvine Scientific
Croyez Bioscience
Beijing Sino Biological
Abbkine Scientific
Yeasen Biotechnology (Shanghai)
Dalian Meilun Biotechnology
Shanghai Zhong Qiao Xin Zhou Biotechnology
Suzhou Novoprotein Scientific
Nanjing Okay Biotechnology
Cellverse
Beijing T&L Biotechnology
EIAAB SCIENCE
Shanghai DiLab Biotechnology
Segment by Type
TGF-β1
TGF-β2
TGF-β3
by Application
Hospital
Research Institute
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Recombinant Human Transforming Growth Factor-β manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Recombinant Human Transforming Growth Factor-β sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Recombinant Human Transforming Growth Factor-β Market Overview
1.1 Product Definition
1.2 Recombinant Human Transforming Growth Factor-β by Type
1.2.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Type: 2025 vs 2032
1.2.2 TGF-β1
1.2.3 TGF-β2
1.2.4 TGF-β3
1.3 Recombinant Human Transforming Growth Factor-β by Application
1.3.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Recombinant Human Transforming Growth Factor-β Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Transforming Growth Factor-β Revenue 2021–2032
1.4.2 Global Recombinant Human Transforming Growth Factor-β Sales 2021–2032
1.4.3 Global Recombinant Human Transforming Growth Factor-β Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human Transforming Growth Factor-β Market Competition by Manufacturers
2.1 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human Transforming Growth Factor-β Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
2.8 Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Transforming Growth Factor-β Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue
2.8.3 Global Recombinant Human Transforming Growth Factor-β Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Transforming Growth Factor-β Market Scenario by Region
3.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2032
3.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2026
3.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2027–2032
3.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2027–2032
3.4 North America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.4.1 North America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.4.3 North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2032)
4.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2026)
4.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027–2032)
4.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human Transforming Growth Factor-β Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2032)
5.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2026)
5.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027–2032)
5.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human Transforming Growth Factor-β Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Company Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Atlantis Bioscience
6.3.1 Atlantis Bioscience Company Information
6.3.2 Atlantis Bioscience Description and Business Overview
6.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.3.5 Atlantis Bioscience Recent Developments/Updates
6.4 Sigma-Aldrich
6.4.1 Sigma-Aldrich Company Information
6.4.2 Sigma-Aldrich Description and Business Overview
6.4.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
6.4.5 Sigma-Aldrich Recent Developments/Updates
6.5 MedChemExpress
6.5.1 MedChemExpress Company Information
6.5.2 MedChemExpress Description and Business Overview
6.5.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
6.5.5 MedChemExpress Recent Developments/Updates
6.6 Miltenyi Biotec
6.6.1 Miltenyi Biotec Company Information
6.6.2 Miltenyi Biotec Description and Business Overview
6.6.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
6.6.5 Miltenyi Biotec Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 Proteintech
6.8.1 Proteintech Company Information
6.8.2 Proteintech Description and Business Overview
6.8.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
6.8.5 Proteintech Recent Developments/Updates
6.9 Cell Guidance Systems
6.9.1 Cell Guidance Systems Company Information
6.9.2 Cell Guidance Systems Description and Business Overview
6.9.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.9.5 Cell Guidance Systems Recent Developments/Updates
6.10 Cell Signaling Technology
6.10.1 Cell Signaling Technology Company Information
6.10.2 Cell Signaling Technology Description and Business Overview
6.10.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.10.5 Cell Signaling Technology Recent Developments/Updates
6.11 Qkine
6.11.1 Qkine Company Information
6.11.2 Qkine Description and Business Overview
6.11.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
6.11.5 Qkine Recent Developments/Updates
6.12 ACROBiosystems
6.12.1 ACROBiosystems Company Information
6.12.2 ACROBiosystems Description and Business Overview
6.12.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.12.5 ACROBiosystems Recent Developments/Updates
6.13 FUJIFILM Irvine Scientific
6.13.1 FUJIFILM Irvine Scientific Company Information
6.13.2 FUJIFILM Irvine Scientific Description and Business Overview
6.13.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.13.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.14 Croyez Bioscience
6.14.1 Croyez Bioscience Company Information
6.14.2 Croyez Bioscience Description and Business Overview
6.14.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.14.5 Croyez Bioscience Recent Developments/Updates
6.15 Beijing Sino Biological
6.15.1 Beijing Sino Biological Company Information
6.15.2 Beijing Sino Biological Description and Business Overview
6.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
6.15.5 Beijing Sino Biological Recent Developments/Updates
6.16 Abbkine Scientific
6.16.1 Abbkine Scientific Company Information
6.16.2 Abbkine Scientific Description and Business Overview
6.16.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.16.5 Abbkine Scientific Recent Developments/Updates
6.17 Yeasen Biotechnology (Shanghai)
6.17.1 Yeasen Biotechnology (Shanghai) Company Information
6.17.2 Yeasen Biotechnology (Shanghai) Description and Business Overview
6.17.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
6.17.5 Yeasen Biotechnology (Shanghai) Recent Developments/Updates
6.18 Dalian Meilun Biotechnology
6.18.1 Dalian Meilun Biotechnology Company Information
6.18.2 Dalian Meilun Biotechnology Description and Business Overview
6.18.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.18.5 Dalian Meilun Biotechnology Recent Developments/Updates
6.19 Shanghai Zhong Qiao Xin Zhou Biotechnology
6.19.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
6.19.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
6.19.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.19.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
6.20 Suzhou Novoprotein Scientific
6.20.1 Suzhou Novoprotein Scientific Company Information
6.20.2 Suzhou Novoprotein Scientific Description and Business Overview
6.20.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.20.5 Suzhou Novoprotein Scientific Recent Developments/Updates
6.21 Nanjing Okay Biotechnology
6.21.1 Nanjing Okay Biotechnology Company Information
6.21.2 Nanjing Okay Biotechnology Description and Business Overview
6.21.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.21.5 Nanjing Okay Biotechnology Recent Developments/Updates
6.22 Cellverse
6.22.1 Cellverse Company Information
6.22.2 Cellverse Description and Business Overview
6.22.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
6.22.5 Cellverse Recent Developments/Updates
6.23 Beijing T&L Biotechnology
6.23.1 Beijing T&L Biotechnology Company Information
6.23.2 Beijing T&L Biotechnology Description and Business Overview
6.23.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.23.5 Beijing T&L Biotechnology Recent Developments/Updates
6.24 EIAAB SCIENCE
6.24.1 EIAAB SCIENCE Company Information
6.24.2 EIAAB SCIENCE Description and Business Overview
6.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
6.24.5 EIAAB SCIENCE Recent Developments/Updates
6.25 Shanghai DiLab Biotechnology
6.25.1 Shanghai DiLab Biotechnology Company Information
6.25.2 Shanghai DiLab Biotechnology Description and Business Overview
6.25.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.25.5 Shanghai DiLab Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Transforming Growth Factor-β Industry Chain Analysis
7.2 Recombinant Human Transforming Growth Factor-β Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Transforming Growth Factor-β Production Mode & Process Analysis
7.4 Recombinant Human Transforming Growth Factor-β Sales and Marketing
7.4.1 Recombinant Human Transforming Growth Factor-β Sales Channels
7.4.2 Recombinant Human Transforming Growth Factor-β Distributors
7.5 Recombinant Human Transforming Growth Factor-β Customer Analysis
8 Recombinant Human Transforming Growth Factor-β Market Dynamics
8.1 Recombinant Human Transforming Growth Factor-β Industry Trends
8.2 Recombinant Human Transforming Growth Factor-β Market Drivers
8.3 Recombinant Human Transforming Growth Factor-β Market Challenges
8.4 Recombinant Human Transforming Growth Factor-β Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Recombinant Human Transforming Growth Factor-β by Type
1.2.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Type: 2025 vs 2032
1.2.2 TGF-β1
1.2.3 TGF-β2
1.2.4 TGF-β3
1.3 Recombinant Human Transforming Growth Factor-β by Application
1.3.1 Global Recombinant Human Transforming Growth Factor-β Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Global Recombinant Human Transforming Growth Factor-β Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Transforming Growth Factor-β Revenue 2021–2032
1.4.2 Global Recombinant Human Transforming Growth Factor-β Sales 2021–2032
1.4.3 Global Recombinant Human Transforming Growth Factor-β Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Recombinant Human Transforming Growth Factor-β Market Competition by Manufacturers
2.1 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
2.2 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Recombinant Human Transforming Growth Factor-β Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
2.7 Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
2.8 Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Transforming Growth Factor-β Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue
2.8.3 Global Recombinant Human Transforming Growth Factor-β Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Transforming Growth Factor-β Market Scenario by Region
3.1 Global Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2032
3.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021–2026
3.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2027–2032
3.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2032
3.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021–2026
3.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2027–2032
3.4 North America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.4.1 North America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.4.3 North America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.5.3 Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Transforming Growth Factor-β Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (2021–2032)
3.6.3 Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.7.3 Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Transforming Growth Factor-β Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021–2032)
3.8.3 Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2032)
4.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021–2026)
4.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027–2032)
4.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2032)
4.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2032)
4.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021–2026)
4.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027–2032)
4.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2032)
4.3 Global Recombinant Human Transforming Growth Factor-β Price by Type (2021–2032)
5 Segment by Application
5.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2032)
5.1.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021–2026)
5.1.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027–2032)
5.1.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2032)
5.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2032)
5.2.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021–2026)
5.2.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027–2032)
5.2.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2032)
5.3 Global Recombinant Human Transforming Growth Factor-β Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Abcam
6.2.1 Abcam Company Information
6.2.2 Abcam Description and Business Overview
6.2.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
6.2.5 Abcam Recent Developments/Updates
6.3 Atlantis Bioscience
6.3.1 Atlantis Bioscience Company Information
6.3.2 Atlantis Bioscience Description and Business Overview
6.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.3.5 Atlantis Bioscience Recent Developments/Updates
6.4 Sigma-Aldrich
6.4.1 Sigma-Aldrich Company Information
6.4.2 Sigma-Aldrich Description and Business Overview
6.4.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
6.4.5 Sigma-Aldrich Recent Developments/Updates
6.5 MedChemExpress
6.5.1 MedChemExpress Company Information
6.5.2 MedChemExpress Description and Business Overview
6.5.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
6.5.5 MedChemExpress Recent Developments/Updates
6.6 Miltenyi Biotec
6.6.1 Miltenyi Biotec Company Information
6.6.2 Miltenyi Biotec Description and Business Overview
6.6.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
6.6.5 Miltenyi Biotec Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 Proteintech
6.8.1 Proteintech Company Information
6.8.2 Proteintech Description and Business Overview
6.8.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
6.8.5 Proteintech Recent Developments/Updates
6.9 Cell Guidance Systems
6.9.1 Cell Guidance Systems Company Information
6.9.2 Cell Guidance Systems Description and Business Overview
6.9.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.9.5 Cell Guidance Systems Recent Developments/Updates
6.10 Cell Signaling Technology
6.10.1 Cell Signaling Technology Company Information
6.10.2 Cell Signaling Technology Description and Business Overview
6.10.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.10.5 Cell Signaling Technology Recent Developments/Updates
6.11 Qkine
6.11.1 Qkine Company Information
6.11.2 Qkine Description and Business Overview
6.11.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
6.11.5 Qkine Recent Developments/Updates
6.12 ACROBiosystems
6.12.1 ACROBiosystems Company Information
6.12.2 ACROBiosystems Description and Business Overview
6.12.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
6.12.5 ACROBiosystems Recent Developments/Updates
6.13 FUJIFILM Irvine Scientific
6.13.1 FUJIFILM Irvine Scientific Company Information
6.13.2 FUJIFILM Irvine Scientific Description and Business Overview
6.13.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.13.5 FUJIFILM Irvine Scientific Recent Developments/Updates
6.14 Croyez Bioscience
6.14.1 Croyez Bioscience Company Information
6.14.2 Croyez Bioscience Description and Business Overview
6.14.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
6.14.5 Croyez Bioscience Recent Developments/Updates
6.15 Beijing Sino Biological
6.15.1 Beijing Sino Biological Company Information
6.15.2 Beijing Sino Biological Description and Business Overview
6.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
6.15.5 Beijing Sino Biological Recent Developments/Updates
6.16 Abbkine Scientific
6.16.1 Abbkine Scientific Company Information
6.16.2 Abbkine Scientific Description and Business Overview
6.16.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.16.5 Abbkine Scientific Recent Developments/Updates
6.17 Yeasen Biotechnology (Shanghai)
6.17.1 Yeasen Biotechnology (Shanghai) Company Information
6.17.2 Yeasen Biotechnology (Shanghai) Description and Business Overview
6.17.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
6.17.5 Yeasen Biotechnology (Shanghai) Recent Developments/Updates
6.18 Dalian Meilun Biotechnology
6.18.1 Dalian Meilun Biotechnology Company Information
6.18.2 Dalian Meilun Biotechnology Description and Business Overview
6.18.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.18.5 Dalian Meilun Biotechnology Recent Developments/Updates
6.19 Shanghai Zhong Qiao Xin Zhou Biotechnology
6.19.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
6.19.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
6.19.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.19.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
6.20 Suzhou Novoprotein Scientific
6.20.1 Suzhou Novoprotein Scientific Company Information
6.20.2 Suzhou Novoprotein Scientific Description and Business Overview
6.20.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
6.20.5 Suzhou Novoprotein Scientific Recent Developments/Updates
6.21 Nanjing Okay Biotechnology
6.21.1 Nanjing Okay Biotechnology Company Information
6.21.2 Nanjing Okay Biotechnology Description and Business Overview
6.21.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.21.5 Nanjing Okay Biotechnology Recent Developments/Updates
6.22 Cellverse
6.22.1 Cellverse Company Information
6.22.2 Cellverse Description and Business Overview
6.22.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
6.22.5 Cellverse Recent Developments/Updates
6.23 Beijing T&L Biotechnology
6.23.1 Beijing T&L Biotechnology Company Information
6.23.2 Beijing T&L Biotechnology Description and Business Overview
6.23.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.23.5 Beijing T&L Biotechnology Recent Developments/Updates
6.24 EIAAB SCIENCE
6.24.1 EIAAB SCIENCE Company Information
6.24.2 EIAAB SCIENCE Description and Business Overview
6.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
6.24.5 EIAAB SCIENCE Recent Developments/Updates
6.25 Shanghai DiLab Biotechnology
6.25.1 Shanghai DiLab Biotechnology Company Information
6.25.2 Shanghai DiLab Biotechnology Description and Business Overview
6.25.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
6.25.5 Shanghai DiLab Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Transforming Growth Factor-β Industry Chain Analysis
7.2 Recombinant Human Transforming Growth Factor-β Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Transforming Growth Factor-β Production Mode & Process Analysis
7.4 Recombinant Human Transforming Growth Factor-β Sales and Marketing
7.4.1 Recombinant Human Transforming Growth Factor-β Sales Channels
7.4.2 Recombinant Human Transforming Growth Factor-β Distributors
7.5 Recombinant Human Transforming Growth Factor-β Customer Analysis
8 Recombinant Human Transforming Growth Factor-β Market Dynamics
8.1 Recombinant Human Transforming Growth Factor-β Industry Trends
8.2 Recombinant Human Transforming Growth Factor-β Market Drivers
8.3 Recombinant Human Transforming Growth Factor-β Market Challenges
8.4 Recombinant Human Transforming Growth Factor-β Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation by Manufacturers in 2025
Table 4. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
Table 12. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Transforming Growth Factor-β Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Transforming Growth Factor-β Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
Table 18. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2026)
Table 19. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
Table 20. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027–2032)
Table 21. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
Table 22. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2026)
Table 23. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
Table 24. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027–2032)
Table 25. North America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 27. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 28. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 29. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 32. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 33. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 42. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 50. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2021–2026)
Table 51. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2027–2032)
Table 52. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2026)
Table 53. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027–2032)
Table 54. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2026)
Table 57. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027–2032)
Table 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2026)
Table 59. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2027–2032)
Table 60. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2021–2026)
Table 61. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2027–2032)
Table 62. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2026)
Table 63. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027–2032)
Table 64. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2026)
Table 67. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027–2032)
Table 68. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2026)
Table 69. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2027–2032)
Table 70. Thermo Fisher Company Information
Table 71. Thermo Fisher Description and Business Overview
Table 72. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product
Table 74. Thermo Fisher Recent Developments/Updates
Table 75. Abcam Company Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Abcam Recombinant Human Transforming Growth Factor-β Product
Table 79. Abcam Recent Developments/Updates
Table 80. Atlantis Bioscience Company Information
Table 81. Atlantis Bioscience Description and Business Overview
Table 82. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product
Table 84. Atlantis Bioscience Recent Developments/Updates
Table 85. Sigma-Aldrich Company Information
Table 86. Sigma-Aldrich Description and Business Overview
Table 87. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product
Table 89. Sigma-Aldrich Recent Developments/Updates
Table 90. MedChemExpress Company Information
Table 91. MedChemExpress Description and Business Overview
Table 92. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. MedChemExpress Recombinant Human Transforming Growth Factor-β Product
Table 94. MedChemExpress Recent Developments/Updates
Table 95. Miltenyi Biotec Company Information
Table 96. Miltenyi Biotec Description and Business Overview
Table 97. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product
Table 99. Miltenyi Biotec Recent Developments/Updates
Table 100. Bio-Techne Company Information
Table 101. Bio-Techne Description and Business Overview
Table 102. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bio-Techne Recombinant Human Transforming Growth Factor-β Product
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Proteintech Company Information
Table 106. Proteintech Description and Business Overview
Table 107. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Proteintech Recombinant Human Transforming Growth Factor-β Product
Table 109. Proteintech Recent Developments/Updates
Table 110. Cell Guidance Systems Company Information
Table 111. Cell Guidance Systems Description and Business Overview
Table 112. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product
Table 114. Cell Guidance Systems Recent Developments/Updates
Table 115. Cell Signaling Technology Company Information
Table 116. Cell Signaling Technology Description and Business Overview
Table 117. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product
Table 119. Cell Signaling Technology Recent Developments/Updates
Table 120. Qkine Company Information
Table 121. Qkine Description and Business Overview
Table 122. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Qkine Recombinant Human Transforming Growth Factor-β Product
Table 124. Qkine Recent Developments/Updates
Table 125. ACROBiosystems Company Information
Table 126. ACROBiosystems Description and Business Overview
Table 127. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product
Table 129. ACROBiosystems Recent Developments/Updates
Table 130. FUJIFILM Irvine Scientific Company Information
Table 131. FUJIFILM Irvine Scientific Description and Business Overview
Table 132. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product
Table 134. FUJIFILM Irvine Scientific Recent Developments/Updates
Table 135. Croyez Bioscience Company Information
Table 136. Croyez Bioscience Description and Business Overview
Table 137. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product
Table 139. Croyez Bioscience Recent Developments/Updates
Table 140. Beijing Sino Biological Company Information
Table 141. Beijing Sino Biological Description and Business Overview
Table 142. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product
Table 144. Beijing Sino Biological Recent Developments/Updates
Table 145. Abbkine Scientific Company Information
Table 146. Abbkine Scientific Description and Business Overview
Table 147. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product
Table 149. Abbkine Scientific Recent Developments/Updates
Table 150. Yeasen Biotechnology (Shanghai) Company Information
Table 151. Yeasen Biotechnology (Shanghai) Description and Business Overview
Table 152. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product
Table 154. Yeasen Biotechnology (Shanghai) Recent Developments/Updates
Table 155. Dalian Meilun Biotechnology Company Information
Table 156. Dalian Meilun Biotechnology Description and Business Overview
Table 157. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 159. Dalian Meilun Biotechnology Recent Developments/Updates
Table 160. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
Table 161. Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
Table 162. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 164. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
Table 165. Suzhou Novoprotein Scientific Company Information
Table 166. Suzhou Novoprotein Scientific Description and Business Overview
Table 167. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product
Table 169. Suzhou Novoprotein Scientific Recent Developments/Updates
Table 170. Nanjing Okay Biotechnology Company Information
Table 171. Nanjing Okay Biotechnology Description and Business Overview
Table 172. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 174. Nanjing Okay Biotechnology Recent Developments/Updates
Table 175. Cellverse Company Information
Table 176. Cellverse Description and Business Overview
Table 177. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Cellverse Recombinant Human Transforming Growth Factor-β Product
Table 179. Cellverse Recent Developments/Updates
Table 180. Beijing T&L Biotechnology Company Information
Table 181. Beijing T&L Biotechnology Description and Business Overview
Table 182. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 184. Beijing T&L Biotechnology Recent Developments/Updates
Table 185. EIAAB SCIENCE Company Information
Table 186. EIAAB SCIENCE Description and Business Overview
Table 187. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product
Table 189. EIAAB SCIENCE Recent Developments/Updates
Table 190. Shanghai DiLab Biotechnology Company Information
Table 191. Shanghai DiLab Biotechnology Description and Business Overview
Table 192. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 194. Shanghai DiLab Biotechnology Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Recombinant Human Transforming Growth Factor-β Distributors List
Table 198. Recombinant Human Transforming Growth Factor-β Customers List
Table 199. Recombinant Human Transforming Growth Factor-β Market Trends
Table 200. Recombinant Human Transforming Growth Factor-β Market Drivers
Table 201. Recombinant Human Transforming Growth Factor-β Market Challenges
Table 202. Recombinant Human Transforming Growth Factor-β Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Transforming Growth Factor-β
Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Share by Type: 2025 & 2032
Figure 4. TGF-β1 Product Picture
Figure 5. TGF-β2 Product Picture
Figure 6. TGF-β3 Product Picture
Figure 7. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Recombinant Human Transforming Growth Factor-β Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Research Institute
Figure 11. Others
Figure 12. Global Recombinant Human Transforming Growth Factor-β Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Recombinant Human Transforming Growth Factor-β Market Size (US$ Million), 2021–2032
Figure 14. Global Recombinant Human Transforming Growth Factor-β Sales (K Units), 2021–2032
Figure 15. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit), 2021–2032
Figure 16. Recombinant Human Transforming Growth Factor-β Report Years Considered
Figure 17. Recombinant Human Transforming Growth Factor-β Sales Share by Manufacturers in 2025
Figure 18. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players: Market Share by Revenue in Recombinant Human Transforming Growth Factor-β in 2025
Figure 20. Recombinant Human Transforming Growth Factor-β Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 23. North America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 24. United States Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 27. Europe Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 28. Germany Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2032)
Figure 35. China Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
Figure 54. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
Figure 55. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
Figure 57. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
Figure 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2032)
Figure 59. Recombinant Human Transforming Growth Factor-β Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Recombinant Human Transforming Growth Factor-β Market Competitive Situation by Manufacturers in 2025
Table 4. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Recombinant Human Transforming Growth Factor-β, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Product Types and Applications
Table 12. Global Key Manufacturers of Recombinant Human Transforming Growth Factor-β, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Transforming Growth Factor-β Companies by Tier (Tier 1, Tier 2, Tier 3), based on Recombinant Human Transforming Growth Factor-β Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
Table 18. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2026)
Table 19. Global Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
Table 20. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2027–2032)
Table 21. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
Table 22. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2026)
Table 23. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
Table 24. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027–2032)
Table 25. North America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 27. North America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 28. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 29. North America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 32. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 33. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 42. Latin America Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue by Country (US$ Million), 2027–2032
Table 50. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2021–2026)
Table 51. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Type (2027–2032)
Table 52. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021–2026)
Table 53. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027–2032)
Table 54. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021–2026)
Table 57. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027–2032)
Table 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2026)
Table 59. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2027–2032)
Table 60. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2021–2026)
Table 61. Global Recombinant Human Transforming Growth Factor-β Sales (K Units) by Application (2027–2032)
Table 62. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021–2026)
Table 63. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027–2032)
Table 64. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Recombinant Human Transforming Growth Factor-β Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021–2026)
Table 67. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027–2032)
Table 68. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2026)
Table 69. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2027–2032)
Table 70. Thermo Fisher Company Information
Table 71. Thermo Fisher Description and Business Overview
Table 72. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product
Table 74. Thermo Fisher Recent Developments/Updates
Table 75. Abcam Company Information
Table 76. Abcam Description and Business Overview
Table 77. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Abcam Recombinant Human Transforming Growth Factor-β Product
Table 79. Abcam Recent Developments/Updates
Table 80. Atlantis Bioscience Company Information
Table 81. Atlantis Bioscience Description and Business Overview
Table 82. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product
Table 84. Atlantis Bioscience Recent Developments/Updates
Table 85. Sigma-Aldrich Company Information
Table 86. Sigma-Aldrich Description and Business Overview
Table 87. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product
Table 89. Sigma-Aldrich Recent Developments/Updates
Table 90. MedChemExpress Company Information
Table 91. MedChemExpress Description and Business Overview
Table 92. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. MedChemExpress Recombinant Human Transforming Growth Factor-β Product
Table 94. MedChemExpress Recent Developments/Updates
Table 95. Miltenyi Biotec Company Information
Table 96. Miltenyi Biotec Description and Business Overview
Table 97. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product
Table 99. Miltenyi Biotec Recent Developments/Updates
Table 100. Bio-Techne Company Information
Table 101. Bio-Techne Description and Business Overview
Table 102. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Bio-Techne Recombinant Human Transforming Growth Factor-β Product
Table 104. Bio-Techne Recent Developments/Updates
Table 105. Proteintech Company Information
Table 106. Proteintech Description and Business Overview
Table 107. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Proteintech Recombinant Human Transforming Growth Factor-β Product
Table 109. Proteintech Recent Developments/Updates
Table 110. Cell Guidance Systems Company Information
Table 111. Cell Guidance Systems Description and Business Overview
Table 112. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product
Table 114. Cell Guidance Systems Recent Developments/Updates
Table 115. Cell Signaling Technology Company Information
Table 116. Cell Signaling Technology Description and Business Overview
Table 117. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product
Table 119. Cell Signaling Technology Recent Developments/Updates
Table 120. Qkine Company Information
Table 121. Qkine Description and Business Overview
Table 122. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Qkine Recombinant Human Transforming Growth Factor-β Product
Table 124. Qkine Recent Developments/Updates
Table 125. ACROBiosystems Company Information
Table 126. ACROBiosystems Description and Business Overview
Table 127. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product
Table 129. ACROBiosystems Recent Developments/Updates
Table 130. FUJIFILM Irvine Scientific Company Information
Table 131. FUJIFILM Irvine Scientific Description and Business Overview
Table 132. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product
Table 134. FUJIFILM Irvine Scientific Recent Developments/Updates
Table 135. Croyez Bioscience Company Information
Table 136. Croyez Bioscience Description and Business Overview
Table 137. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product
Table 139. Croyez Bioscience Recent Developments/Updates
Table 140. Beijing Sino Biological Company Information
Table 141. Beijing Sino Biological Description and Business Overview
Table 142. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product
Table 144. Beijing Sino Biological Recent Developments/Updates
Table 145. Abbkine Scientific Company Information
Table 146. Abbkine Scientific Description and Business Overview
Table 147. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product
Table 149. Abbkine Scientific Recent Developments/Updates
Table 150. Yeasen Biotechnology (Shanghai) Company Information
Table 151. Yeasen Biotechnology (Shanghai) Description and Business Overview
Table 152. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product
Table 154. Yeasen Biotechnology (Shanghai) Recent Developments/Updates
Table 155. Dalian Meilun Biotechnology Company Information
Table 156. Dalian Meilun Biotechnology Description and Business Overview
Table 157. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 159. Dalian Meilun Biotechnology Recent Developments/Updates
Table 160. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
Table 161. Shanghai Zhong Qiao Xin Zhou Biotechnology Description and Business Overview
Table 162. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 164. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments/Updates
Table 165. Suzhou Novoprotein Scientific Company Information
Table 166. Suzhou Novoprotein Scientific Description and Business Overview
Table 167. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product
Table 169. Suzhou Novoprotein Scientific Recent Developments/Updates
Table 170. Nanjing Okay Biotechnology Company Information
Table 171. Nanjing Okay Biotechnology Description and Business Overview
Table 172. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 174. Nanjing Okay Biotechnology Recent Developments/Updates
Table 175. Cellverse Company Information
Table 176. Cellverse Description and Business Overview
Table 177. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Cellverse Recombinant Human Transforming Growth Factor-β Product
Table 179. Cellverse Recent Developments/Updates
Table 180. Beijing T&L Biotechnology Company Information
Table 181. Beijing T&L Biotechnology Description and Business Overview
Table 182. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 183. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 184. Beijing T&L Biotechnology Recent Developments/Updates
Table 185. EIAAB SCIENCE Company Information
Table 186. EIAAB SCIENCE Description and Business Overview
Table 187. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 188. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product
Table 189. EIAAB SCIENCE Recent Developments/Updates
Table 190. Shanghai DiLab Biotechnology Company Information
Table 191. Shanghai DiLab Biotechnology Description and Business Overview
Table 192. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 193. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product
Table 194. Shanghai DiLab Biotechnology Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Recombinant Human Transforming Growth Factor-β Distributors List
Table 198. Recombinant Human Transforming Growth Factor-β Customers List
Table 199. Recombinant Human Transforming Growth Factor-β Market Trends
Table 200. Recombinant Human Transforming Growth Factor-β Market Drivers
Table 201. Recombinant Human Transforming Growth Factor-β Market Challenges
Table 202. Recombinant Human Transforming Growth Factor-β Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
Table 206. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Transforming Growth Factor-β
Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Share by Type: 2025 & 2032
Figure 4. TGF-β1 Product Picture
Figure 5. TGF-β2 Product Picture
Figure 6. TGF-β3 Product Picture
Figure 7. Global Recombinant Human Transforming Growth Factor-β Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Recombinant Human Transforming Growth Factor-β Market Share by Application: 2025 & 2032
Figure 9. Hospital
Figure 10. Research Institute
Figure 11. Others
Figure 12. Global Recombinant Human Transforming Growth Factor-β Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Recombinant Human Transforming Growth Factor-β Market Size (US$ Million), 2021–2032
Figure 14. Global Recombinant Human Transforming Growth Factor-β Sales (K Units), 2021–2032
Figure 15. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit), 2021–2032
Figure 16. Recombinant Human Transforming Growth Factor-β Report Years Considered
Figure 17. Recombinant Human Transforming Growth Factor-β Sales Share by Manufacturers in 2025
Figure 18. Global Recombinant Human Transforming Growth Factor-β Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Recombinant Human Transforming Growth Factor-β Players: Market Share by Revenue in Recombinant Human Transforming Growth Factor-β in 2025
Figure 20. Recombinant Human Transforming Growth Factor-β Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Recombinant Human Transforming Growth Factor-β Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 23. North America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 24. United States Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 27. Europe Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 28. Germany Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021–2032)
Figure 35. China Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 43. Latin America Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Recombinant Human Transforming Growth Factor-β Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
Figure 54. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Type (2021–2032)
Figure 55. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
Figure 57. Global Revenue Market Share of Recombinant Human Transforming Growth Factor-β by Application (2021–2032)
Figure 58. Global Recombinant Human Transforming Growth Factor-β Price (US$/Unit) by Application (2021–2032)
Figure 59. Recombinant Human Transforming Growth Factor-β Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232